Patient monitoring equipment developer and supplier LiDCO Group has received regulatory approval for the LiDCOrapid cardiac output monitor in South Korea.
The South Korean distributor is Globaluck and it will be promoting the high usage programme. This is being offered in the US and the UK.
In the year to January 2019, revenues fell from £8.3m to £7.3m, while the loss was £2m. The loss could be halved this year.
© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Omega Diagnostics will lose money this year, but it is on course to become profitable in 2020-21 as sales of the VISITECT CD4 test.
House broker Shore Capital has slashed its pre-tax profit forecast for engineer Tricorn Group by two-thirds to £420,000.
Evgen Pharma has entered into an agreement with The University of Dundee for the use of SFX-01 in a clinical trial in non-alcoholic steatohepatitis and liver fibrosis, where there is no existing treatment.